Clinical Trial Update: A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of fixed-dose combination therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese subjects with asthm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-05-29